Amarin Corp Plc (AMRN)

[Birdbrain Ideas]

I would ask:

1) With many of Amarin's base costs covered by U.S. revenue, can we expect a much faster road to profits in Europe even before revenues there rise dramatically?

And

2) Given how slowly Canadian revenues are rising two years after Vascepa was approved, can we expect the same in Europe or are there reasons we can expect some meaningful sales numbers much sooner in Europe?